Log in to save to my catalogue

Engineering of Ribosome-inactivating Proteins for Improving Pharmacological Properties

Engineering of Ribosome-inactivating Proteins for Improving Pharmacological Properties

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8227c97ccac14841a984ff9dc7c6df68

Engineering of Ribosome-inactivating Proteins for Improving Pharmacological Properties

About this item

Full title

Engineering of Ribosome-inactivating Proteins for Improving Pharmacological Properties

Publisher

Switzerland: MDPI AG

Journal title

Toxins, 2020-03, Vol.12 (3), p.167

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Ribosome-inactivating proteins (RIPs) are N-glycosidases, which depurinate a specific adenine residue in the conserved α-sarcin/ricin loop (α-SRL) of rRNA. This loop is important for anchoring elongation factor (EF-G for prokaryote or eEF2 for eukaryote) in mRNA translocation. Translation is inhibited after the attack. RIPs therefore may have been...

Alternative Titles

Full title

Engineering of Ribosome-inactivating Proteins for Improving Pharmacological Properties

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8227c97ccac14841a984ff9dc7c6df68

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8227c97ccac14841a984ff9dc7c6df68

Other Identifiers

ISSN

2072-6651

E-ISSN

2072-6651

DOI

10.3390/toxins12030167

How to access this item